Large-scale testing (Phase 3)UnknownNCT03293108
What this trial is testing
Comparing Efficacy and Safety of AryoGen Pharmed Biosimilar Denosumab 60 mg (Arylia) Versus Prolia® in Improvement of Bone Mineral Densitometry (BMD) Among Osteoporotic Postmenopausal Women
Who this might be right for
Osteoporosis
AryoGen Pharmed Co. 190